Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSEPH GHATA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1215258017
CMS profile
1223446
Location
OKLAHOMA CITY, OK

General Payments · PY2018–2024

$24,697.34

  • Reported across 69 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,696.70

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $164.10 3
PY2019 $92.24 1
PY2020 $15.00 1
PY2021 $207.63 6
PY2022 $6,012.72 7
PY2023 $13,508.95 19
PY2024 $4,696.70 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $21.47 02/06/2024 Food and Beverage Undisputed 01/23/2026 1111583098 CMS
Amgen Inc. $16.03 05/07/2024 Food and Beverage Undisputed 01/23/2026 1117260195 CMS
ANI Pharmaceuticals, Inc. $19.07 08/14/2024 Food and Beverage Undisputed 01/23/2026 1091142906 CMS
Ardelyx, Inc. $17.65 02/21/2024 Food and Beverage Undisputed 01/23/2026 1146681875 CMS
Bayer Healthcare Pharmaceuticals Inc. $5.86 01/04/2024 Food and Beverage Undisputed 01/23/2026 1086090305 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,025.00 04/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1086230434 CMS
Bayer Healthcare Pharmaceuticals Inc. $7.28 05/23/2024 Food and Beverage Undisputed 01/23/2026 1086084371 CMS
Bayer Healthcare Pharmaceuticals Inc. $7.73 09/13/2024 Food and Beverage Undisputed 01/23/2026 1086088237 CMS
Bayer Healthcare Pharmaceuticals Inc. $12.88 11/14/2024 Food and Beverage Undisputed 01/23/2026 1086081698 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,640.00 11/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1086184898 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.58 12/04/2024 Food and Beverage Undisputed 01/23/2026 1086259906 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,640.00 12/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1086270256 CMS
Cycle Pharmaceuticals Inc $5.55 09/19/2024 Food and Beverage Undisputed 01/23/2026 1154920384 CMS
Novartis Pharmaceuticals Corporation $23.00 04/05/2024 Food and Beverage Undisputed 01/23/2026 1086929743 CMS
Novartis Pharmaceuticals Corporation $17.76 05/01/2024 Food and Beverage Undisputed 01/23/2026 1086929745 CMS
Novo Nordisk Inc $13.19 05/16/2024 Food and Beverage Undisputed 01/23/2026 1097177476 CMS
Otsuka America Pharmaceutical, Inc. $23.13 04/11/2024 Food and Beverage Undisputed 01/23/2026 1118897482 CMS
Travere Therapeutics, Inc. $7.93 02/12/2024 Food and Beverage Undisputed 01/23/2026 1149878772 CMS
Travere Therapeutics, Inc. $5.99 03/05/2024 Food and Beverage Undisputed 01/23/2026 1149878757 CMS
Travere Therapeutics, Inc. $16.89 03/05/2024 Education Undisputed 01/23/2026 1149878776 CMS
Travere Therapeutics, Inc. $23.22 04/02/2024 Food and Beverage Undisputed 01/23/2026 1149878788 CMS
Travere Therapeutics, Inc. $7.88 04/23/2024 Food and Beverage Undisputed 01/23/2026 1149878768 CMS
Travere Therapeutics, Inc. $6.57 05/14/2024 Food and Beverage Undisputed 01/23/2026 1149878760 CMS
Travere Therapeutics, Inc. $2.38 05/28/2024 Education Undisputed 01/23/2026 1149878741 CMS
Travere Therapeutics, Inc. $25.97 05/28/2024 Food and Beverage Undisputed 01/23/2026 1149878792 CMS
Travere Therapeutics, Inc. $2.38 07/08/2024 Education Undisputed 01/23/2026 1149878744 CMS
Travere Therapeutics, Inc. $3.08 07/22/2024 Education Undisputed 01/23/2026 1149878748 CMS
Travere Therapeutics, Inc. $4.82 08/02/2024 Food and Beverage Undisputed 01/23/2026 1149878753 CMS
Travere Therapeutics, Inc. $18.94 08/15/2024 Food and Beverage Undisputed 01/23/2026 1149878784 CMS
Travere Therapeutics, Inc. $16.89 08/27/2024 Education Undisputed 01/23/2026 1149878780 CMS
Travere Therapeutics, Inc. $7.09 08/29/2024 Food and Beverage Undisputed 01/23/2026 1149878764 CMS
Travere Therapeutics, Inc. $28.49 11/06/2024 Food and Beverage Undisputed 01/23/2026 1149878796 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.